Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
An introductory training course on the duties of an ONS chapter president.
To address travel restrictions from the COVID-19 coronavirus pandemic while delivering important learning and resources ONS members rely on, during its March conference call the ONS Board of Directors made several decisions to host its meetings and content virtually throughout 2020.
Congratulations to ONS Director-at-Large Valerie Burger, RN, MA, MS, OCN®, CPN, whom the ONS Board of Directors selected as treasurer, and ONS Director-at-Large Darcy Burbage, DNP, RN, AOCN®, CBCN®, whom it selected as secretary, during its April 13, 2021, meeting.
Nurses in oncology who compound hazardous drugs (HDs) may be familiar with the U.S. Pharmacopeial Convention (USP) because of chapter <795> related to compounding nonsterile medications and chapter <797> addressing compounding sterile medications. But what is USP really, and why does it have an impact on oncology nursing practice?
The Hematology/Oncology Pharmacy Association (HOPA) and Oncology Nursing Society (ONS) have partnered to develop a joint position statement in advance of an upcoming compliance deadline for U.S. Pharmacopeia Chapter <800> (USP <800>).